InnoVet Inc. preclinical data

IVT (West Palm Beach, Fla.) announced that results of an animal trial do not support immuno-stimulation as the agent's presumed mode of action.

The trial used dexamethasone to suppress immune function. IVET-629 prevented the induced decrease in hemoglobin levels, but had no statistically significant effects on measures of immune stimulation. ...